OABIW vs. ATNFW, SXTPW, DRTSW, APLMW, ARTLW, BCDAW, BCTXW, CDIOW, CTCXW, and SAVAW
Should you be buying OmniAb stock or one of its competitors? The main competitors of OmniAb include 180 Life Sciences (ATNFW), 60 Degrees Pharmaceuticals (SXTPW), Alpha Tau Medical (DRTSW), Apollomics (APLMW), Artelo Biosciences (ARTLW), BioCardia (BCDAW), BriaCell Therapeutics (BCTXW), Cardio Diagnostics (CDIOW), Carmell (CTCXW), and Cassava Sciences (SAVAW). These companies are all part of the "biotechnology" industry.
180 Life Sciences (NASDAQ:ATNFW) and OmniAb (NASDAQ:OABIW) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their earnings, analyst recommendations, risk, institutional ownership, media sentiment, valuation, dividends, community ranking and profitability.
In the previous week, OmniAb's average media sentiment score of 0.00 equaled 180 Life Sciences'average media sentiment score.
180 Life Sciences and OmniAb both received 0 outperform votes by MarketBeat users.
Summary
OmniAb beats 180 Life Sciences on 1 of the 1 factors compared between the two stocks.
Get OmniAb News Delivered to You Automatically
Sign up to receive the latest news and ratings for OABIW and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding OABIW and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
OABIW vs. The Competition
Related Companies and Tools
